公司資料
Vincerx Pharma 股價、新聞與催化劑
- 股票代碼:
- VINC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.01 USD (0.00%)
收盤價
最後更新: 2026年10月1日
—
市值
股價為何變動
截至 2026年10月1日，VINC 股價變化不大，收於 $0.0150。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Vincerx Pharma is an oncology company focused on targeted therapies and differentiated cancer medicines. Its strategy has centered on precision oncology and program prioritization.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Vincerx sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical data, pipeline selection, and the ability to convert oncology science into value.
生技產業定位
Vincerx is a small-cap oncology catalyst name whose valuation is highly sensitive to development progress.
未來催化劑
- Vincerx is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live oncology milestone. The market is mainly watching what remains after the unwind.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。